JANEL CLARK: Open Payments
NPI 1578951752 · GRANITE CITY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,837 in 86 payments from 13 companies in 2025. Trend: 2023 $802 · 2024 $454 · 2025 $1,837
Food & beverage: $1,739Education: $98
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $503 |
| Teva Pharmaceuticals USA, Inc. | 12 | $288 |
| Vanda Pharmaceuticals Inc. | 6 | $249 |
| Janssen Pharmaceuticals, Inc | 10 | $217 |
| Neurocrine BioSciences, Inc. | 6 | $144 |
| Axsome Therapeutics, Inc. | 1 | $84 |
| Lilly USA, LLC | 3 | $73 |
| Alkermes, Inc. | 3 | $65 |
| ViiV Healthcare Company | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
Products named: VRAYLAR, FANAPT, INVEGA SUSTENNA, UZEDY, INGREZZA, Auvelity, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
